Stahel R - Search Results

1

Relapse pattern and second-line treatment following multimodality treatment for malignant pleural mesothelioma.

Kostron A, Friess M, Crameri O, Inci I, Schneiter D, Hillinger S, Stahel R, Weder W, Opitz I. Kostron A, et al. Among authors: stahel r. Eur J Cardiothorac Surg. 2016 May;49(5):1516-23. doi: 10.1093/ejcts/ezv398. Epub 2015 Nov 20. Eur J Cardiothorac Surg. 2016. PMID: 26590183

2

Malignant pleural mesothelioma.

Stahel RA, Felley-Bosco E, Opitz I, Weder W. Stahel RA, et al. Future Oncol. 2009 Apr;5(3):391-402. doi: 10.2217/fon.09.7. Future Oncol. 2009. PMID: 19374545 Review.

3

Improving the outcome in malignant pleural mesothelioma: nonaggressive or aggressive approach?

Stahel RA, Weder W. Stahel RA, et al. Curr Opin Oncol. 2009 Mar;21(2):124-30. doi: 10.1097/CCO.0b013e328324bc30. Curr Opin Oncol. 2009. PMID: 19532013 Review.

4

A New Prognostic Score Supporting Treatment Allocation for Multimodality Therapy for Malignant Pleural Mesothelioma: A Review of 12 Years' Experience.

Opitz I, Friess M, Kestenholz P, Schneiter D, Frauenfelder T, Nguyen-Kim TD, Seifert B, Hoda MA, Klepetko W, Stahel RA, Weder W. Opitz I, et al. J Thorac Oncol. 2015 Nov;10(11):1634-41. doi: 10.1097/JTO.0000000000000661. J Thorac Oncol. 2015. PMID: 26317916 Free article. Review.

5

Diagnostic accuracy of sequential co-registered PET+MR in comparison to PET/CT in local thoracic staging of malignant pleural mesothelioma.

Martini K, Meier A, Opitz I, Weder W, Veit-Haibach P, Stahel RA, Frauenfelder T. Martini K, et al. Lung Cancer. 2016 Apr;94:40-5. doi: 10.1016/j.lungcan.2016.01.017. Epub 2016 Jan 28. Lung Cancer. 2016. PMID: 26973205

6

Neoadjuvant chemotherapy in malignant pleural mesothelioma.

Stahel R, Weder W. Stahel R, et al. Lung Cancer. 2005 Jul;49 Suppl 1:S69-70. doi: 10.1016/j.lungcan.2005.03.014. Lung Cancer. 2005. PMID: 15950804 No abstract available.

7

Incidence and management of complications after neoadjuvant chemotherapy followed by extrapleural pneumonectomy for malignant pleural mesothelioma.

Opitz I, Kestenholz P, Lardinois D, Müller M, Rousson V, Schneiter D, Stahel R, Weder W. Opitz I, et al. Among authors: stahel r. Eur J Cardiothorac Surg. 2006 Apr;29(4):579-84. doi: 10.1016/j.ejcts.2006.01.015. Epub 2006 Feb 21. Eur J Cardiothorac Surg. 2006. PMID: 16495068 Free article.

8

PTEN expression is a strong predictor of survival in mesothelioma patients.

Opitz I, Soltermann A, Abaecherli M, Hinterberger M, Probst-Hensch N, Stahel R, Moch H, Weder W. Opitz I, et al. Among authors: stahel r. Eur J Cardiothorac Surg. 2008 Mar;33(3):502-6. doi: 10.1016/j.ejcts.2007.09.045. Epub 2008 Jan 8. Eur J Cardiothorac Surg. 2008. PMID: 18248818 Free article.

9

Multimodality strategies in malignant pleural mesothelioma.

Weder W, Opitz I, Stahel R. Weder W, et al. Among authors: stahel r. Semin Thorac Cardiovasc Surg. 2009 Summer;21(2):172-6. doi: 10.1053/j.semtcvs.2009.07.004. Semin Thorac Cardiovasc Surg. 2009. PMID: 19822290 Review.

10

Pneumonectomy is a valuable treatment option after neoadjuvant therapy for stage III non-small-cell lung cancer.

Weder W, Collaud S, Eberhardt WE, Hillinger S, Welter S, Stahel R, Stamatis G. Weder W, et al. Among authors: stahel r. J Thorac Cardiovasc Surg. 2010 Jun;139(6):1424-30. doi: 10.1016/j.jtcvs.2010.02.039. Epub 2010 Apr 24. J Thorac Cardiovasc Surg. 2010. PMID: 20416887 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

442 results

Search Page

Filters